Enabling patient-centric cancer R&D with primary tissues and Pharmacoscopy®

Time: 10:00 am



  • Primary tissue are as close as one can get to an actual patient in preclinical R&D
  • Quantifying drug action in these complex samples, however, is analytically very challenging
  • With Pharmacoscopy® we can interrogate drug activity in live human tumour tissues at the single cell level at scale and with demonstrated clinical translatability